Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gentaur
Kampenhout, Vlaams Brabant, Belgiumgentaur.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Gentaur does not develop therapeutics but provides commercial access to over three million life science research products including antibodies, proteins, gene editing services/tools (e.g., CRISPR), diagnostic kits, cell lines and more. It also offers contract microbiology/biotech testing services for pharma/biotech/food/cosmetics industries[1][2][3][5][6].
- Therapeutic areas
- Other
- Modalities
- AntibodyMonoclonal antibodyPolyclonal antibodyRecombinant proteinPeptidesSmall moleculeCell line productsGene editing tools (CRISPR/Cas9, RNA interference)Plasmid vectorsDiagnostic kit
- Industry
- Non-Drug Biotech
02
Partnerships
Distributes products from over 400–700 manufacturers/suppliers worldwide
Beyond the preview
Go deeper on Gentaur.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gentaur.